Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
48 participants
OBSERVATIONAL
2005-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Babies are exposed to these sugars by placental transport during pregnancy and through mother's breast milk after they are born. For the preterm infant, we do not know if breast milk gives enough of these sugars compared to what the baby gets during pregnancy.
A maternal blood sample and blood samples from the baby's umbilical cord will provide us with background information for developing a supplement of special sugars that can be added to infant formulas to provide the amount that the baby usually gets during pregnancy and from breast milk.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association Between Blood Volume, the Interval From Delivery to Cord Clamping, and Number of Umbilical Cord Milking
NCT04898868
Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants
NCT01523769
Epidural Analgesia, Beta-Endorphin Concentrations in Colostrum, and Infant Neurobehavior as Breast-Feeding Predictors
NCT01191970
The Effect of Cord Milking on Hemodynamic Status of Preterm Infants
NCT01487187
Newborn Cortical Response to Pain and Non Pharmacological Analgesia
NCT03389789
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
30-33 weeks
mother infant pairs with gestation of 30-33 weeks
No interventions assigned to this group
34-37 weeks
mother infant pairs with gestation of 34-37 weeks
No interventions assigned to this group
38-42 weeks
mother infant pairs with gestation of 38-42 weeks
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Delivered infants appropriate weight for gestational age (between 10% and 90%)
Exclusion Criteria
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Agriculture (USDA)
FED
University of Arkansas
OTHER
Arkansas Children's Hospital Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Arkansas for Medical Sciences
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
31247
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.